Last reviewed · How we verify

NCT07131618: CryoPN

The Effect of Cryocompression on Peripheral Neuropathy in Patients Receiving Chemotherapy for Gynecological Cancer

Not yet recruiting NA Last updated 20 August 2025
What this trial tests

NA trial testing cryocompression in Gynecological Cancers in 78 participants. Not yet recruiting.

Timeline
10 August 2025
Primary endpoint
28 November 2025
31 December 2025

Quick facts

Lead sponsorMersin University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment78
Start date10 August 2025
Primary completion28 November 2025
Estimated completion31 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

18 and older, female only, with Gynecological Cancers or Peripheral Neuropathy Due to Chemotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study Design: This study is designed as a prospective, randomized controlled experimental study aiming to determine the effect of cryocompression therapy, applied during chemotherapy, on peripheral neuropathy symptoms in women with gynecologic cancers. Research Hypotheses: * H₀: Cryocompression therapy has no effect on peripheral neuropathy. * H₁: Cryocompression therapy has an effect on peripheral neuropathy. Study Population: The study population will consist of women over the age of 18 living in Mersin, Türkiye, who are diagnosed with gynecologic cancer and undergoing chemotherapy between August 10 and December 31, 2025.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gynecological Cancers

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07131618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing